Hankook Cosmetics Manufacturing Co Ltd

Hankook Cosmetics has a liquidity position that is medium in risk, with a current ratio of 4.55 and a cash and equivalents balance of 54,017,564,740 KRW. The company's liquidity_fpt metric indicates a strong ability to meet short-term obligations, supported by a free cash flow of 26,879,706,090 KRW. However, the company has a net cash position that is negative after subtracting total debt, which is a key liquidity flag. Profitability metrics show that the company is performing well relative to industry norms. The return on equity (ROE) of 26.15% and return on assets (ROA) of 13.77% are both above the typical thresholds for the Personal Products industry. The gross profit margin of 26.5% and operating margin of 17.8% also indicate strong cost control and pricing power. The company's revenue is split between two segments: Cosmetics and Other. The Cosmetics segment is the primary revenue driver, though the exact revenue concentration is not disclosed. The Other segment includes the sale of auxiliary materials and other products, which may be less significant in terms of revenue contribution. The geographic exposure is primarily to Korea, with no material international operations disclosed in the financial snapshot. Looking at the growth trajectory, the company has demonstrated a consistent revenue and profit growth. The operating cash flow of 36,305,075,110 KRW and free cash flow of 26,879,706,090 KRW suggest that the company is generating sufficient cash to support operations and reinvestment. The capital expenditure of -2,259,083,540 KRW indicates a reduction in capital spending, which may be a strategic decision to preserve cash or a reflection of asset depreciation. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio of 0.61 is relatively low, indicating a conservative capital structure. However, the negative net cash position after subtracting total debt is a concern. The dilution risk is low, with no significant dilution sources identified in the risk assessment. The company has not issued additional shares recently, and there is no indication of a pending equity offering. Recent events and filings do not show any material changes in the company's operations or financial position. The company's financial statements are consistent with its historical performance, and there are no significant one-time events or accounting adjustments that would affect the valuation or risk profile. The company's operating cash flow and free cash flow remain strong, supporting its current valuation metrics.